Inhaled corticosteroids and bone mineral density at school age: A follow-up study after early childhood wheezing

Summary Objective The aim of the study was to evaluate the association between previous use of ICS and bone mineral density (BMD) at school age in a cohort followed after early childhood wheezing. Methods As part of a prospective follow‐up study after hospitalization for wheezing at <24 months of...

Full description

Saved in:
Bibliographic Details
Published inPediatric pulmonology Vol. 50; no. 1; pp. 1 - 7
Main Authors Sidoroff, Virpi H., Ylinen, Mari K., Kröger, Liisa M., Kröger, Heikki P.J., Korppi, Matti O.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.01.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Objective The aim of the study was to evaluate the association between previous use of ICS and bone mineral density (BMD) at school age in a cohort followed after early childhood wheezing. Methods As part of a prospective follow‐up study after hospitalization for wheezing at <24 months of age, BMD was measured in 89 children at 12.3 (median) years of age. Data on ICS use were collected by interviewing the parents, and this was supplemented with data from patient records. Cumulative doses and the duration of ICS use were calculated. Areal BMD (BMDareal, g/cm2) was measured by dual energy X‐ray absorptiometry (DXA), and apparent volumetric BMD (aBMDvol, g/cm3) was calculated, for the lumbar spine and femoral neck. Weight, height and pubertal stage were recorded. Findings Age, sex, and pubertal stage were significantly associated with BMDareal and aBMDvol of the lumbar spine and BMDareal of the femoral neck. The regular use of ICS for >6 months at age <6 years was associated with a lower BMD of the lumbar spine. A lower BMDareal and aBMDvol of the femoral neck were associated with higher cumulative doses of ICS at age 0–12.3 (median) years. The results were robust to adjustment for age, sex, pubertal stage, height, weight, and use of systemic steroids. Conclusion ICS use during childhood may be related to a decrease in BMD at late school age. It is important to use the lowest possible ICS dose that maintains adequate asthma control. Pediatr Pulmonol. 2015; 50:1–7. © 2013 Wiley Periodicals, Inc.
Bibliography:Tampere Tuberculosis Foundation
ArticleID:PPUL22968
The National Graduation School of Clinical Investigations
North-Karelia Central Hospital, Joensuu, Finland
ark:/67375/WNG-TC8V0GQJ-3
istex:A3B9F0C752174F2F5F6CC583F9A8400C7A5B4AA2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:8755-6863
1099-0496
DOI:10.1002/ppul.22968